The metabolism of different immunoglobulin classes in irradiated mice.
Explore the source record for details and available documents.
Animals↗
Biomedical subjects
F Malet
Publications and source records attributed to F Malet.
Ciprofloxacin ophthalmic solution versus rifamycin ophthalmic solution for the treatment of conjunctivitis and blepharitis.
The efficacy and safety of ciprofloxacin (0.3%) ophthalmic solution and rifamycin (1%) ophthalmic solution for the treatment of bacterial conjunctivitis and blepharitis was compared in this randomized, double-masked, parallel-group study. Forty-one patients, 19 on ciprofloxacin and 22 on rifamycin, were culture-positive on admission and evaluated for efficacy. There was clinical improvement in more than 90% of patients in each group at the end of the seven-day treatment period. However, clinical cure rates on day 7 appeared to be higher with ciprofloxacin (53%) than rifamycin (23%; p = 0.061, Mann-Whitney test). Bacteriological eradication rates were comparable: the infecting organisms were eradicated in 68% of patients on ciprofloxacin and 77% with rifamycin. There were no serious adverse reactions to either treatment. One patient in each group was withdrawn on account of a mild allergy. In conclusion, topical ciprofloxacin was effective and well tolerated and would be a particularly useful agent for the treatment of bacterial conjunctivitis and blepharitis.
Acute Disease↗
Comparative evaluation of efficacy and safety of ciprofloxacin and norfloxacin ophthalmic solutions.
The efficacy and safety of ciprofloxacin ophthalmic solution 0.3% and norfloxacin ophthalmic solution 0.3% in the treatment of bacterial conjunctivitis and blepharitis were compared in a double masked randomised study. A total of 131 patients, 65 treated with ciprofloxacin (42 with conjunctivitis and 23 with blepharitis) and 66 treated with norfloxacin (39 with conjunctivitis and 27 with blepharitis) were enrolled in the study at five centres in France. In the efficacy population, pathogens were eradicated or reduced in 96% (24/25) of patients in the ciprofloxacin group and 89% (24/27) in the norfloxacin group. There was no difference between treatments with regard to eradication of particular pathogens. In the efficacy population, clinical cure or improvement was seen in 96% of the patients (24/25 in the ciprofloxacin group and 26/27 in the norfloxacin group). There were no significant differences between ciprofloxacin and norfloxacin with respect to improvements in four symptoms or ten clinical signs. No serious treatment-related adverse events were reported and both ciprofloxacin and norfloxacin were well tolerated.
Anti-Infective Agents↗
Inferior steepening is associated with thinning of the inferotemporal cornea.
PURPOSE: Videokeratography has enabled detection of inferior steepening patterns in patients thereby designated as keratoconus suspects. Since no information about the corneal thickness of these eyes is available, we studied several patients with such patterns, and compared the corneal thickness of their eyes with that of normals. METHODS: Three groups of patients who had undergone videokeratography were studied with ultrasonic pachymetry centrally and in four quadrants at the 3-mm clear zone: 44 eyes with true keratoconus, 23 eyes of individuals with inferior steepening of the cornea who were family members of patients with keratoconus; and 44 normal eyes never fitted with contact lenses. The corneal thickness of the eyes in the first two groups was then compared with that in the third using ANOVA and Student's t test. RESULTS: Corneal thickness in the normal eyes and in those with inferior steepening was similar in all except the inferotemporal quadrant. In this quadrant, the corneas of the eyes with inferior steepening were thinner than those of the normal eyes: 544 +/- 32 microns vs 581 +/- 30 microns (p < .05) CONCLUSION: Eyes with inferior steepening on videokeratography have thinner inferotemporal corneas than normal eyes.
Adult↗